Mycobacterium avium disease: progress at last.
作者信息
Bates J H
出版信息
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1737-8. doi: 10.1164/ajrccm.153.6.8665029.
PMID:8665029
Abstract
摘要
相似文献
1
Mycobacterium avium disease: progress at last.鸟分枝杆菌病：终于有进展了。
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1737-8. doi: 10.1164/ajrccm.153.6.8665029.
2
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.克拉霉素或利福布汀单独或联合用于艾滋病患者鸟分枝杆菌复合群疾病的一级预防：一项随机、双盲、安慰剂对照试验。艾滋病临床试验组196/特里·贝恩艾滋病临床研究社区项目009方案团队。
J Infect Dis. 2000 Apr;181(4):1289-97. doi: 10.1086/315380. Epub 2000 Apr 13.
3
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1990-1. doi: 10.1164/ajrccm.153.6.8665069.
4
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.从接受含克拉霉素治疗方案的艾滋病患者中分离出的克拉霉素敏感和耐药鸟分枝杆菌菌株的比较。
J Infect. 2000 Jan;40(1):49-54. doi: 10.1053/jinf.1999.0539.
5
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.用于肺部鸟分枝杆菌复合群的克拉霉素治疗方案。首批50例患者。
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1766-72. doi: 10.1164/ajrccm.153.6.8665032.
6
Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.预防克拉霉素耐药鸟分枝杆菌复合群的产生。
Drugs. 1997;54 Suppl 2:23-7; discussion 28-9. doi: 10.2165/00003495-199700542-00006.
7
Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.鸟分枝杆菌临床分离株在抗菌治疗前及治疗期间的定量培养和药敏试验。
Res Microbiol. 1994 Mar-Apr;145(3):188-96. doi: 10.1016/0923-2508(94)90017-5.
8
Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.艾滋病患者播散性鸟分枝杆菌复合群感染的当前预防和治疗策略。
Pharmacotherapy. 1998 Jul-Aug;18(4):738-47.
9
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.克拉霉素预防播散性鸟分枝杆菌复合群感染——疗效与获得性耐药
Clin Infect Dis. 1998 Oct;27(4):813-5. doi: 10.1086/514960.
10
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.一项关于克拉霉素预防晚期获得性免疫缺陷综合征患者播散性鸟分枝杆菌复合体感染的随机试验。
N Engl J Med. 1996 Aug 8;335(6):384-91. doi: 10.1056/NEJM199608083350603.
引用本文的文献
1
Proteomic characterisation of bovine and avian purified protein derivatives and identification of specific antigens for serodiagnosis of bovine tuberculosis.牛和禽纯化蛋白衍生物的蛋白质组学表征以及牛结核病血清学诊断特异性抗原的鉴定
Clin Proteomics. 2017 Nov 2;14:36. doi: 10.1186/s12014-017-9171-z. eCollection 2017.
2
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.大环内酯类/氮杂内酯类药物治疗结节性/支气管扩张型鸟分枝杆菌复合群肺病。
Chest. 2014 Aug;146(2):276-282. doi: 10.1378/chest.13-2538.
3
Activities of poloxamer CRL-1072 against Mycobacterium avium in macrophage culture and in mice.泊洛沙姆CRL - 1072在巨噬细胞培养物和小鼠中对鸟分枝杆菌的活性。
Antimicrob Agents Chemother. 1999 Dec;43(12):2898-903. doi: 10.1128/AAC.43.12.2898.
4
Risk-benefit assessment of therapies for Mycobacterium avium complex infections.鸟分枝杆菌复合群感染治疗的风险效益评估。
Drug Saf. 1999 Aug;21(2):137-52. doi: 10.2165/00002018-199921020-00006.
5
Multiplex PCR assay for immediate identification of the infecting species in patients with mycobacterial disease.用于快速鉴定分枝杆菌病患者感染菌种的多重聚合酶链反应检测法。
J Clin Microbiol. 1997 Jun;35(6):1492-8. doi: 10.1128/jcm.35.6.1492-1498.1997.
Zotero 插件